An enhanced prognostic score for overall survival of patients with

The Enhanced International Prognostic Index for Diffuse Large B‐cell Lymphoma

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Frontiers Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer

Prognostic laboratory score to predict 14-day mortality in terminally ill patients with respiratory malignancy

Hemato, Free Full-Text

PDF] Usefulness of two clinical (CBC and PETHEMA) scores for predicting early death in patients with acute promyelocytic leukemia: A single-center study in Mexico City

A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients

Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study - The Lancet Regional Health – Western

A Prognostic Score for Advanced Hodgkin's Disease

Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases

Figure 2 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Glasgow Prognostic Score as a Prognostic Clinical Marker in T4 Esophageal Squamous Cell Carcinoma